- Researchers have found that a combination treatment of three existing drugs can slow disease progression in retinal degenerations.
- Inherited retinal degenerations (IRDs) are genetic diseases causing vision loss, with few treatment options available, creating an unmet medical need.
- The combination treatment includes metoprolol, tamsulosin, and bromocriptine, which target intracellular messengers believed to exacerbate the disease.
- The study suggests that repurposing existing drugs offers potential for treating rare diseases, such as IRDs, faster and at lower costs.
- Further clinical trials are needed to test the effectiveness and safety of this combination treatment in humans with retinal degeneration.
Source link
Ophthalmology, Retinal degenerations, Combination therapy